Chang; Kwen-Jen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chang; Kwen-Jen.The latest application filed is for "method of treating parkinson's disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity".

Company Profile

0.24.24

Chang; Kwen-Jen - Chapel Hill NC
Chang; Kwen-Jen - Chapell Hill NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of treating Parkinson's Disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity Grant 10,071,093 - Chang , et al. September 11, 2	2018-09-11
Method Of Treating Parkinson's Disease With A Diarylmethylpiperazine Compounds Exhibiting Delta Opioid Receptor Agonist Activity App 20170290823 - CHANG; KWEN-JEN ; et al.	2017-10-12
Delta Opioid Receptor Agonist Compounds App 20160200689 - CHANG; KWEN-JEN ; et al.	2016-07-14
Delta opioid receptor agonist compounds Grant 9,296,707 - Chang , et al. March 29, 2	2016-03-29
Delta Opioid Receptor Agonist Compounds App 20150018372 - CHANG; KWEN-JEN ; et al.	2015-01-15
Method Of Treating Parkinson's Disease With A Diarylmethylpiperazine Compounds Exhibiting Delta Opioid Receptor Agonist Activity App 20140315922 - CHANG; KWEN-JEN ; et al.	2014-10-23
Delta opioid receptor agonist compounds Grant 8,865,721 - Chang , et al. October 21, 2	2014-10-21
Method of treating Parkinson's Disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity Grant 8,642,599 - Chang , et al. February 4, 2	2014-02-04
Delta Opioid Receptor Agonist Compounds App 20140031367 - CHANG; KWEN-JEN ; et al.	2014-01-30
Method of treating sexual dysfunctions with delta opioid receptor agonist compounds Grant 8,575,169 - Chang , et al. November 5, 2	2013-11-05
Delta opioid receptor agonist compounds Grant 8,551,998 - Chang , et al. October 8, 2	2013-10-08
Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists Grant 8,476,280 - Chang , et al. July 2, 2	2013-07-02
Method of treating sexual dysfunctions with delta opioid receptor agonist compounds App 20130053326 - Chang; Kwen-Jen ; et al.	2013-02-28
Delta Opioid Receptor Agonist Compounds App 20120220601 - CHANG; KWEN-JEN ; et al.	2012-08-30
Compositions of novel opioid compounds and method of use thereof Grant 7,683,168 - Jan , et al. March 23, 2	2010-03-23
Compositions And Methods For Reducing Respiratory Depression And Attendant Side Effects Of Mu Opioid Compounds App 20080193383 - Chang; Kwen-Jen ; et al.	2008-08-14
Cardioprotective Delta Opioid Receptor Agonists And Methods Of Using Same App 20080125443 - Chang; Kwen-Jen ; et al.	2008-05-29
Cardioprotective delta opioid receptor agonists and methods of using same Grant 7,314,880 - Chang , et al. January 1, 2	2008-01-01
Enantiomerically Pure Opioid Diarylmethylpiperazine App 20070197786 - CHANG; KWEN-JEN	2007-08-23
Delta Opioid Receptor Agonist Compounds App 20070173515 - Chang; Kwen-Jen ; et al.	2007-07-26
Method Of Treating Parkinson's Disease With Diarylmethylpiperazine Compounds Exhibiting Delta Receptor Agonist Activity App 20070066625 - Chang; Kwen-Jen ; et al.	2007-03-22
Enantiomerically pure opioid diarylmethylpiperazine as a cardioprotection agent Grant 7,189,725 - Chang March 13, 2	2007-03-13
Compositions of novel opioid compounds and method of use thereof App 20070043028 - Jan; Shyi-Tai ; et al.	2007-02-22
Method of treating depression with delta receptor agonist compounds Grant 7,030,124 - Chang , et al. April 18, 2	2006-04-18
Enantiomerically pure opioid diarylmethylpiperazine as a cardioprotection agent App 20060004016 - Chang; Kwen-Jen	2006-01-05
Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds App 20050255151 - Chang, Kwen-Jen ; et al.	2005-11-17
Enantiomerically pure opioid diarylmethylpiperzine and methods of using same Grant 6,924,288 - Chang August 2, 2	2005-08-02
Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds Grant 6,919,350 - Chang , et al. July 19, 2	2005-07-19
Cardioprotective delta opioid receptor agonists and methods of using same App 20040171622 - Chang, Kwen-Jen ; et al.	2004-09-02
Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists App 20040002503 - Chang, Kwen-Jen ; et al.	2004-01-01
Method of treating sexual dysfunctions with delta opioid receptor agonist compounds App 20030186872 - Chang, Kwen-Jen ; et al.	2003-10-02
Method of treating depression with delta receptor agonist compounds App 20030144299 - Chang, Kwen-Jen ; et al.	2003-07-31
Enantiomerically pure opioid diarylmethylpiperzine and methods of using same App 20030114462 - Chang, Kwen-Jen	2003-06-19
Compositions and Methods for Reducing Respiratory Depression and Attendant SIde Effects of Mu Opioid Compounds App 20020111359 - Chang , Kwen-Jen ; et al.	2002-08-15
Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives App 20020052007 - Chang, Kwen Jen ; et al.	2002-05-02
Methods for reducing respiratory depression and attendant side effects of mu opioid compounds Grant 6,300,332 - Chang , et al. October 9, 2	2001-10-09
Opioid diarylmethylpiperazines and piperidines Grant 5,854,249 - Chang , et al. December 29, 1	1998-12-29
Opioid compounds Grant 5,681,830 - Chang , et al. October 28, 1	1997-10-28
Opioid diarylmethylpiperazines and piperdines Grant 5,658,908 - Chang , et al. August 19, 1	1997-08-19
Opioid compounds and methods for making therefor Grant 5,574,159 - Chang , et al. November 12, 1	1996-11-12
Opioid compounds and methods for using same Grant 5,552,404 - Chang , et al. September 3, 1	1996-09-03
Assay method and compounds Grant 4,231,923 - Miller , et al. November 4, 1	1980-11-04

Company Registrations

SEC

0001314245

CHANG KWEN JEN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.